{
    "2020-11-16": [
        [
            {
                "time": "2020-11-16",
                "original_text": "【爱美客|事件点评】利拉鲁肽注射液获临床批件，减肥（重）领域布局增量可期【安信医药马帅团队】",
                "features": {
                    "keywords": [
                        "利拉鲁肽",
                        "注射液",
                        "临床批件",
                        "减肥",
                        "增量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-16",
                "original_text": "迈瑞医疗年内遭神秘股东三度减持，医疗器械不如医药“香”？ 减持股份数量较大。",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "减持",
                        "医疗器械",
                        "医药"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-11-16",
                "original_text": "恒瑞医药：子公司SHR-1314注射液临床试验获国家药监局批准",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR-1314",
                        "注射液",
                        "临床试验",
                        "药监局批准"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-16",
                "original_text": "君实生物医保谈判前夕遭狙击？前三季亏损11亿元",
                "features": {
                    "keywords": [
                        "君实生物",
                        "医保谈判",
                        "亏损"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-11-16",
                "original_text": "4200亿医疗巨头怎么了？神秘股东三度减持，7天跌去750亿，更遭机构资金连续大甩卖，基金抱团开始松动？",
                "features": {
                    "keywords": [
                        "医疗巨头",
                        "减持",
                        "机构资金",
                        "基金抱团"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}